BTTX fundamentals
An in-depth look to Better Therapeutics, Inc. operating, investing, and financing activities
BTTX free cash flow for Q3 23 is -5.95 M USD. For 2022, BTTX free cash flow was -29.04 M USD and operating cash flow was -28.93 M USD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM